News
Celyad to Provide First Half 2019 Financial Results & Business Highlights and Host a Conference Call
Celyad Presents Update on Autologous & Allogeneic NKG2D-based CAR-T Therapies in Solid Tumors
Celyad Presents Update on Autologous & Allogeneic NKG2D-based CAR-T Therapies in Solid Tumors
Celyad to Host Conference Call to Review Clinical Update from ESMO 21st World GI Congress
Celyad to Host Conference Call to Review Clinical Update from ESMO 21st World GI Congress
Celyad Announces Strategic Updates to the Autologous r/r AML and MDS Program
Celyad Announces Strategic Updates to the Autologous r/r AML and MDS Program
Celyad to Participate in Upcoming June 2019 Conferences
Celyad to Participate in Upcoming June 2019 Conferences
Celyad to Present Data at 24th Congress of the European Hematology Association
Celyad to Present Data at 24th Congress of the European Hematology Association
Celyad Announces May 2019 Investor Conference Schedule
Celyad Announces May 2019 Investor Conference Schedule
Celyad Announces April 2019 Investor Conference Schedule
Celyad Announces April 2019 Investor Conference Schedule
Celyad to Announce Full Year 2018 Financial Results and Host Conference Call
Celyad to Announce Full Year 2018 Financial Results and Host Conference Call
Celyad to Host R&D Day and Webcast on Monday, March 18 in New York City
Celyad to Host R&D Day and Webcast on Monday, March 18 in New York City
Celyad Appoints Anne Moore as Vice President Corporate Strategy
Celyad Appoints Anne Moore as Vice President Corporate Strategy
Celyad Announces February and March 2019 Investor Conference Schedule
Celyad Announces February and March 2019 Investor Conference Schedule